Gavin Xia - Profile and Investment Details

Investor Profile

Gavin Xia is a Venture Capital based in Shanghai, China with a diverse investment portfolio that includes companies such as Navigant, KSQ Therapeutics, xInnovent BiologicsAbbisko Therapeutics, Microtech Medical, Metacrine, ImmuneOnco Biopharma, Targeting One, Alector, Hangzhou Just Biotherapeutics (Just China), Fortis Therapeutics, Harpoon Therapeutics, Legend Biotech, Elpiscience Biopharmaceuticals, Ansun BioPharma, Geneseeq, Turning Point Therapeutics, ReadCoor, dMed, Singlera Genomics, Singleron Biotechnologies, IMPACT Therapeutics, Nucleix, Geneception, NuVera Medical, CARsgen Therapeutics, Just - Evotec Biologics, Terns Pharmaceuticals, Tmunity Therapeutics, 360 Health, Transcenta, NextCure, Nuohui Health, Regor Therapeutics, InventisBio, EdiGene, Tempest Therapeutics, Gracell Biotechnologies, Sonoma BioTherapeutics, NiKang Therapeutics, Inhibrx, Rongchang Pharmaceutical, Remegen, Mailing Yiliao, Magnolia NeuroSciences, Burning Rock Biotech, Passage Bio, Fountain Medical Development, CanSinoBIO, MabSpace Biosciences, Sansure Biotech, NovoCodex, Gritstone Oncology, Veritas Genetics, ACEA BIO, Peijia Medical, Insilico Medicine, Jacobio Pharmaceuticals, Avedro, ClinChoice昆翎医药, 360 Haoyao, Dizal Pharma, Connect Biopharmaceuticals, Qihan Biotech, Ionova Life Science, . Over time, Gavin Xia has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Gavin Xia is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Genetics, Wellness, Women Founded, Strategic Partnerships, Life Science, Robotics, Information Technology (IT), Manufacturing, Biotechnology, Drug Development, Genomics, Clinical Trials, Research, Health Diagnostics, Medical, B2B, Therapeutics, Personal Health, Pharmaceuticals may find it worthwhile to explore potential connections with Gavin Xia, as their portfolio suggests a familiarity and interest in this area.

Understanding Gavin Xia’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.